The Jordanian Pharmaceutical Manufacturing Company - Public Shareholding Company (ASE:JPHM)

ASE:JPHM Revenue

The Jordanian Pharmaceutical Manufacturing Company - Public Shareholding Company had revenue of 7.97M JOD in the quarter ending June 30, 2026, with 66.66% growth. This brings the company's total for the last twelve months to 24.46M, up 59.75% year-over-year. In the year 2024, The Jordanian Pharmaceutical Manufacturing Company - Public Shareholding Company had annual revenue of 16.86M with 15.66% growth. That makes The Jordanian Pharmaceutical Manufacturing Company - Public Shareholding Company the 30,455th largest company in the world by revenue and 56th in Jordan.

• Revenue (ttm): 24.46M
• Revenue Growth: +59.75%
• P/S Ratio: 2.80
• Revenue / Employee: 50.33K
• Employees: 486
• Market Cap: 68.58M

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Jordan 9.29M 55.1%
• Outside Jordan 7.57M 44.9%

Fiscal year ended Dec 31, 2024 See the full ASE:JPHM breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	16.86M	2.28M	15.66%
Dec 31, 2023	14.58M	-2.38M	-14.03%
Dec 31, 2022	16.96M	1.13M	7.16%
Dec 31, 2021	15.83M	913.21K	6.12%
Dec 31, 2020	14.92M	4.94M	49.49%

Data Source: S&P Global Market Intelligence Last updated: Jul 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 19, 2026

Data Sources Report a data error